Where I see patients (4)
My reviews
Selected research
-
Non-invasive markers of hepatic steatosis and fibrosis following INSTI initiation in women with HIV.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
JAMA
-
A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trial.
Trials
Clinical trials
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Prevalence of hepatic steatosis in PLWH will be reported as the number of participants with hepatic steatosis, defined by controlled attenuation parameter (CAP) ≥263 dB/m, over the total number of participants assessed.
Recruiting
4.8